Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients.

Michael Fiegl; Florian Falkner; Michael Steurer; Niklas Zojer; Georg Hopfinger; Ferdinand Haslbauer; Guntram Winder; Daniela Voskova; Johannes Andel; Alois Lang; Yvona Brychtova; Jiri Mayer; Richard Greil; Günther Gastl

doi:10.1007/s00277-011-1192-5

Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients.

Michael Fiegl
, Florian Falkner
, Michael Steurer
, Niklas Zojer
, Georg Hopfinger (Co-Autor/-in)
, Ferdinand Haslbauer
, Guntram Winder
, Daniela Voskova
, Johannes Andel
, Alois Lang
, Yvona Brychtova
, Jiri Mayer
, Richard Greil (Co-Autor/-in)
, Günther Gastl

Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

7 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	1083-1091
Fachzeitschrift	ANNALS OF HEMATOLOGY
Jahrgang	90
Ausgabenummer	9
DOIs	https://doi.org/10.1007/s00277-011-1192-5
Publikationsstatus	Veröffentlicht - 2011

Zugriff auf Dokument

10.1007/s00277-011-1192-5

Dieses zitieren

Fiegl, M., Falkner, F., Steurer, M., Zojer, N., Hopfinger, G., Haslbauer, F., Winder, G., Voskova, D., Andel, J., Lang, A., Brychtova, Y., Mayer, J., Greil, R., & Gastl, G. (2011). Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients. ANNALS OF HEMATOLOGY , 90(9), 1083-1091. https://doi.org/10.1007/s00277-011-1192-5

Fiegl, Michael ; Falkner, Florian ; Steurer, Michael et al. / Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients. in: ANNALS OF HEMATOLOGY 2011 ; Jahrgang 90, Nr. 9. S. 1083-1091.

@article{c46b014600284bd58c1a36a607fd5d68,

title = "Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients.",

keywords = "NON-HODGKINS-LYMPHOMA, PHASE-II, SUBCUTANEOUS ALEMTUZUMAB, FLUDARABINE, CAMPATH-1H, RITUXIMAB, SURVIVAL, THERAPY, CANCER, GUIDELINES",

author = "Michael Fiegl and Florian Falkner and Michael Steurer and Niklas Zojer and Georg Hopfinger and Ferdinand Haslbauer and Guntram Winder and Daniela Voskova and Johannes Andel and Alois Lang and Yvona Brychtova and Jiri Mayer and Richard Greil and G{\"u}nther Gastl",

note = "R. Greil Department of Internal Medicine III, Private Medical University of Salzburg, Salzburg, Austria",

year = "2011",

doi = "10.1007/s00277-011-1192-5",

language = "English",

volume = "90",

pages = "1083--1091",

journal = "ANNALS OF HEMATOLOGY ",

issn = "0939-5555",

publisher = "Springer Nature",

number = "9",

}

Fiegl, M, Falkner, F, Steurer, M, Zojer, N, Hopfinger, G, Haslbauer, F, Winder, G, Voskova, D, Andel, J, Lang, A, Brychtova, Y, Mayer, J, Greil, R & Gastl, G 2011, 'Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients.', ANNALS OF HEMATOLOGY , Jg. 90, Nr. 9, S. 1083-1091. https://doi.org/10.1007/s00277-011-1192-5

Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients. / Fiegl, Michael; Falkner, Florian; Steurer, Michael et al.
in: ANNALS OF HEMATOLOGY , Jahrgang 90, Nr. 9, 2011, S. 1083-1091.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients.

AU - Fiegl, Michael

AU - Falkner, Florian

AU - Steurer, Michael

AU - Zojer, Niklas

AU - Hopfinger, Georg

AU - Haslbauer, Ferdinand

AU - Winder, Guntram

AU - Voskova, Daniela

AU - Andel, Johannes

AU - Lang, Alois

AU - Brychtova, Yvona

AU - Mayer, Jiri

AU - Greil, Richard

AU - Gastl, Günther

N1 - R. Greil Department of Internal Medicine III, Private Medical University of Salzburg, Salzburg, Austria

PY - 2011

Y1 - 2011

KW - NON-HODGKINS-LYMPHOMA

KW - PHASE-II

KW - SUBCUTANEOUS ALEMTUZUMAB

KW - FLUDARABINE

KW - CAMPATH-1H

KW - RITUXIMAB

KW - SURVIVAL

KW - THERAPY

KW - CANCER

KW - GUIDELINES

U2 - 10.1007/s00277-011-1192-5

DO - 10.1007/s00277-011-1192-5

M3 - Original Article

C2 - 21350830

SN - 0939-5555

VL - 90

SP - 1083

EP - 1091

JO - ANNALS OF HEMATOLOGY

JF - ANNALS OF HEMATOLOGY

IS - 9

ER -

Fiegl M, Falkner F, Steurer M, Zojer N, Hopfinger G, Haslbauer F et al. Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients. ANNALS OF HEMATOLOGY . 2011;90(9):1083-1091. doi: 10.1007/s00277-011-1192-5